France · Delayed Price · Currency is EUR GeNeuro Statistics
Total Valuation
GeNeuro has a market cap or net worth of EUR 952,997. The enterprise value is 12.79 million.
| Market Cap | 952,997 |
| Enterprise Value | 12.79M |
Important Dates
The next estimated earnings date is Friday, September 19, 2025.
| Earnings Date | Sep 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GeNeuro has 29.60 million shares outstanding.
| Current Share Class | 29.60M |
| Shares Outstanding | 29.60M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.32% |
| Float | 8.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.07 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.87 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.26 |
Financial Position
The company has a current ratio of 0.37
| Current Ratio | 0.37 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.35 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -100.64% |
| Return on Invested Capital (ROIC) | -211.83% |
| Return on Capital Employed (ROCE) | -12,773.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -868,059 |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GeNeuro has paid 4,200 in taxes.
| Income Tax | 4,200 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.90% in the last 52 weeks. The beta is 0.80, so GeNeuro's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -63.90% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 29.50 |
| Average Volume (20 Days) | 131,705 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.36M |
| Pretax Income | -14.75M |
| Net Income | -14.76M |
| EBITDA | -14.32M |
| EBIT | -14.36M |
| Earnings Per Share (EPS) | -0.59 |
Balance Sheet
The company has 1.83 million in cash and 13.67 million in debt, giving a net cash position of -11.84 million or -0.40 per share.
| Cash & Cash Equivalents | 1.83M |
| Total Debt | 13.67M |
| Net Cash | -11.84M |
| Net Cash Per Share | -0.40 |
| Equity (Book Value) | -13.78M |
| Book Value Per Share | -0.55 |
| Working Capital | -3.92M |
Cash Flow
In the last 12 months, operating cash flow was -10.15 million and capital expenditures -12,500, giving a free cash flow of -10.16 million.
| Operating Cash Flow | -10.15M |
| Capital Expenditures | -12,500 |
| Free Cash Flow | -10.16M |
| FCF Per Share | -0.34 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GeNeuro does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.96% |
| Shareholder Yield | n/a |
| Earnings Yield | -1,548.48% |
| FCF Yield | -1,066.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |